May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Effect of Intrastromal Injection of Suramin in Treatment of Corneal Angiogenesis in a Rabbit Model
Author Affiliations & Notes
  • M. N. Moraes Filho
    Ophthalomology, Federal University of Sao Paulo, Sao Paulo, Brazil
  • A. S. Moriyama
    Ophthalomology, Federal University of Sao Paulo, Sao Paulo, Brazil
  • E. Dib
    Ophthalomology, Federal University of Sao Paulo, Sao Paulo, Brazil
  • A. A. S. Lima
    Ophthalomology, Federal University of Sao Paulo, Sao Paulo, Brazil
  • E. B. Rodrigues
    Ophthalomology, Federal University of Sao Paulo, Sao Paulo, Brazil
  • D. Freitas
    Ophthalomology, Federal University of Sao Paulo, Sao Paulo, Brazil
  • Footnotes
    Commercial Relationships  M.N. Moraes Filho, None; A.S. Moriyama, None; E. Dib, None; A.A.S. Lima, None; E.B. Rodrigues, None; D. Freitas, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 1497. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. N. Moraes Filho, A. S. Moriyama, E. Dib, A. A. S. Lima, E. B. Rodrigues, D. Freitas; Effect of Intrastromal Injection of Suramin in Treatment of Corneal Angiogenesis in a Rabbit Model. Invest. Ophthalmol. Vis. Sci. 2008;49(13):1497. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To analyze the effect of intrastromal Suramin on experimentally induced corneal neovascularization (NV) in a rabbit model.

Methods: : NV was induced by silk 6.0 suture in peripheral cornea from 8 New Zealand rabbits and were randomly distributed into three groups: Control Group (n=4): intrastromal injection (30G) of Balanced Saline Solution (BSS) 14 days after injury. Suramin Group 1 (n=2): 8mg/0,2mL intrastromal injection (30G) of Suramin 14 days after injury. Suramin Group 2 (n=2): 4mg/0,2mL intrastromal injection (30G) of Suramin 14 days after injury. Biomicroscopic photographies were taken at days 7 (D7), 14 (D14), 21 (D21) and 28 (D28). NV areas (pixels) were processed and morphometrically analyzed by Image J 1.31v software. The area of NV on D14 was considered as 100%. The percent change from this value at D21 and D28 were presented. In addition, the concentration of NV (branches/area) was analyzed.

Results: : Average NV area at D28 was largest in Group 2 (438.1%) followed closely by Group 1 (331.2%). Control group featured smaller areas than Suramin groups (128.2%). NV concentration was higher in Suramin groups at D21 but decreased at D28, compared to control. Unexpected loss of corneal transparency and whitish opaque intrastromal deposit were observed in rabbits from Group 1 and 2 at D21, wich disappeared later compared to control. Intracameral injection of Suramin occurred accidentally in one rabbit (Group 2), however the animal showed no difference in NV area compared to the other from same group.

Conclusions: : Intrastromally injected Suramin may maximize or even yield an intense NV process in comparison to control. We speculate that such unexpected results may be caused either by a direct action of the drug in the corneal stroma or by secondary injection inflammation related.

Keywords: cornea: clinical science • neovascularization • inhibitory receptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×